Press release
Cystic Fibrosis Pipeline, FDA Approvals, Clinical Trials Developments and Companies | Krystal Biotech, Vertex Pharmaceuticals, Translate Bio, Novartis, Algi Pharma, Verona Pharma, and others.
Cystic Fibrosis Pipeline
Key Takeaways from the Cystic Fibrosis Pipeline Report
• DelveInsight's Cystic Fibrosis pipeline report depicts a robust space with 75+ companies working to develop 80+ pipeline therapies for Cystic Fibrosis treatment.
• The leading companies working in the Cystic Fibrosis Market include Krystal Biotech, Vertex Pharmaceuticals, Translate Bio, Novartis, Algi Pharma, Verona Pharma, Atlantic Healthcare, Calithera Biosciences, Horizon Therapeutics, Santhera Pharmaceuticals, Reveragen Biopharma, Spli Sense, GlaxoSmithKline, EmphyCorp, Abbvie, Galapagos NV, Vertex Pharmaceuticals, PathBio Analytics, AstraZeneca, AxentisPharma AG, and others.
• Promising Cystic Fibrosis Pipeline Therapies in the various stages of development include Ciprofloxacin (Cipro Inhale, BAYQ3939), P-1037, Hypertonic Saline, VX-371 + HS, MP-376 (Levofloxacin solution for Inhalation), and others.
• January 2024: Parion Sciences announced a study of Phase 1 & 2 clinical trials for 552-02. The purpose of this study is to evaluate the safety and tolerability of a new inhaled sodium-channel blocker called 552-02 in teens and adults with cystic fibrosis. 552-02 will be inhaled once a day for 14 days using a nebulizer. A small subgroup of patients will donate blood samples for pharmacokinetic analysis to see how 552-02 is absorbed into the blood and eliminated after 14 days of treatment.
• December 2023: Arcturus Therapeutics Inc. announced a study of Phase 1 clinical trials for ARCT-032. Determine the safety, tolerability and pharmacokinetics of single doses of ARCT-032 in healthy adult subjects (Phase 1) and of two doses in Adults with Cystic Fibrosis (Phase 1b).
• October 2023: Vertex Pharmaceuticals Incorporated announced a study of phase 3 clinical trials for ELX/TEZ/IVA and IVA. This study will evaluate the pharmacokinetics (PK), safety, tolerability, pharmacodynamics (PD), and efficacy of ELX/TEZ/IVA in CF subjects 12 to less than (
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/graves-disease-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cystic Fibrosis Pipeline, FDA Approvals, Clinical Trials Developments and Companies | Krystal Biotech, Vertex Pharmaceuticals, Translate Bio, Novartis, Algi Pharma, Verona Pharma, and others. here
News-ID: 3347561 • Views: …
More Releases from DelveInsight Business Research LLP
Oncolytic Virus Cancer Therapy Market | Companies involved: Targovax, Replimune, …
DelveInsight's "Oncolytic Virus Cancer Therapy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Oncolytic Virus Cancer Therapy, historical and forecasted epidemiology as well as the Oncolytic Virus Cancer Therapy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Oncolytic Virus Cancer Therapy market report provides current treatment practices, emerging drugs, Oncolytic Virus Cancer Therapy market share of the…
Lymphocytopenia Market to Witness Growth | AbbVie Inc, BristolMyersSquibb, CSL L …
DelveInsight's "Lymphocytopenia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Lymphocytopenia, historical and forecasted epidemiology as well as the Lymphocytopenia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Lymphocytopenia market report provides current treatment practices, emerging drugs, Lymphocytopenia market share of the individual therapies, and current and forecasted Lymphocytopenia market size from 2019 to 2032 segmented by…
Complex Regional Pain Syndrome Market to Witness Growth by 2032 |Ovid therapeuti …
DelveInsight's "Complex Regional Pain Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Complex Regional Pain Syndrome, historical and forecasted epidemiology as well as the Complex Regional Pain Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Complex Regional Pain Syndrome market report provides current treatment practices, emerging drugs, Complex Regional Pain Syndrome market share of the…
Meningitis Market to Witness Growth by 2032 | Bausch Health Companies Inc., Myla …
DelveInsight's "Meningitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Meningitis, historical and forecasted epidemiology as well as the Meningitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Meningitis market report provides current treatment practices, emerging drugs, Meningitis market share of the individual therapies, and current and forecasted Meningitis market size from 2019 to 2032 segmented by…
More Releases for Cystic
Cystic Fibrosis Market Report-Growth with Industry Study, Detailed Analysis | Cy …
The research study contains an in detail descriptive overview and analysis of the Cystic Fibrosis Market, a summary of the market shares constituted by each component, the annual growth of each sector, and the revenue potential of the section. In addition, Cystic Fibrosis Market production and consumption data are used to determine the geographical features.
Get FREE PDF sample of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=3639856
Top Company Profile Analysis in this Report-
Cystic Fibrosis…
The Cystic Fibrosis Market to Witness Robust Growth Due to Increasing Cases of C …
Cystic fibrosis is a rare, progressive, life-threatening disease results in the formation of thick mucus that builds up in the lungs, digestive tract, and other parts of the body. If left untreated, it leads to severe digestive and respiratory problems as well as other complications such as infections and diabetes. According to the Cystic Fibrosis Foundation, more than 70,000 people are living with cystic fibrosis around the world. As the…
Cystic Fibrosis Therapeutics Market - Forecasts to 2026
As per the research conducted by GME, the Global Cystic Fibrosis Therapeutics Market will grow with a CAGR value of 13.5% by 2026. Cystic fibrosis is becoming more prevalent, resulting in increased awareness, technological improvements, strong pipeline prospects, and expanding R&D initiatives which are some of the factors to influence the growth of the market. The disease has no permanent cure but the symptoms and complications can be reduced by…
Cystic Fibrosis Market Opportunity Analysis, 2018-2026
Cystic fibrosis (CF) is a genetic disorder that usually affects the lungs and may also affect the pancreas, kidneys, liver, and intestine. Long-term repercussions including difficulty in breathing and coughing as a result of recurrent lung infections can be seen in CF. Some of the other signs and symptoms include sinus infections, poor growth, infertility in males, fatty stool, and guild of the fingers and toes. Different individuals may have…
Cystic Fibrosis - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Cystic Fibrosis - Heat Map and Analysis to its growing collection of premium market research reports.
Cystic fibrosis (CF) is a progressive genetic condition and is the result of a patient inheriting a faulty cystic fibroses transmembrane conductance regulator (CFTR) gene from both parents. The defective CFTR genes produce faulty CFTR proteins on the body’s epithelial cells, and result in…
Cystic Fibrosis - Heat Map And Analysis
MarketResearchReports.Biz is providing you Latest Market Research report of "Cystic Fibrosis - Heat Map And Analysis".
Cystic fibrosis (CF) is a progressive genetic condition and is the result of a patient inheriting a faulty cystic fibroses transmembrane conductance regulator (CFTR) gene from both parents. The defective CFTR genes produce faulty CFTR proteins on the body?s epithelial cells, and result in the buildup of a thick and sticky mucus in the lungs…
